Research progress of dydrogesterone in the treatment of endometriosis
European Journal of Obstetrics & Gynecology and Reproductive Biology · 2024-05 · 296 · 120-125
DOI: 10.1016/j.ejogrb.2024.02.034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Obstetrics & Gynecology and Reproductive Biology, 2024-05. Verfasst von Wenlu Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Fujian Provincial Geriatric Hospital, Fuzhou 350003, Fujian Province, China; The First Clinical College of Fujian Medical U…. Hauptthemen laut MEDLINE: Dydrogesterone, Endometriosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fujian Provincial Natural Science Foundation.
Abstract (Originalsprache)
Endometriosis is a common gynecological disease among women of reproductive age. It is a chronic estrogen and progestin related inflammatory disease. At present, the main treatments for endometriosis are drug therapy and surgery. In drug therapy, progesterone is listed as the first-line recommendation in multinational guidelines. Dydrogesterone, as an oral reversal progesterone, can slow down the metabolism of progesterone, inhibit angiogenesis and extracellular matrix degradation to inhibit the proliferation of the ectopic endometrium, induce the atrophy of the ectopic endometrium through the pro-apoptotic pathway, and treat endometriosis through multiple mechanisms of regulating inflammatory factors to reduce inflammation. Clinically, dydrogesterone treatment of endometriosis can relieve patients' symptoms, promote fertility, be used in combination, and is safe. This article will review the mechanism and clinical application of dydrogesterone in the treatment of endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Fujian Provincial Geriatric Hospital, Fuzhou 350003, Fujian Province, China; The First Clinical College of Fujian Medical University, Fuzhou 350004, Fujian Province, China.
- The First Clinical College of Fujian Medical University, Fuzhou 350004, Fujian Province, China.
- The First Clinical College of Fujian Medical University, Fuzhou 350004, Fujian Province, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian…
Förderung
- Fujian Provincial Natural Science Foundation
Zitieren
APA
Tang, W., Zhu, X., Bian, L., & Zhang, B. (2024). Research progress of dydrogesterone in the treatment of endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 296, 120-125. https://doi.org/10.1016/j.ejogrb.2024.02.034
Vancouver
Tang W, Zhu X, Bian L, Zhang B. Research progress of dydrogesterone in the treatment of endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2024;296:120-125. doi:10.1016/j.ejogrb.2024.02.034
BibTeX
@article{Tang2024,
author = {Tang, Wenlu and Zhu, Xiaohong and Bian, Lihong and Zhang, Bin},
title = {Research progress of dydrogesterone in the treatment of endometriosis},
journal = {European Journal of Obstetrics & Gynecology and Reproductive Biology},
year = {2024},
volume = {296},
pages = {120--125},
doi = {10.1016/j.ejogrb.2024.02.034}
}
EUVIMED